Atlas Trials

DESyne X2 Post Market Follow-up Study

Clinical trial NCT04375085 · TERMINATED

Trial details

NCT number
NCT04375085
Sponsor
Elixir Medical Corporation
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2020-09-01
Primary completion
2021-12-28
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.